Randomized Phase II Trial of Erlotinib Alone or With Carboplatin and Paclitaxel in Patients Who Were Never or Light Former Smokers With Advanced Lung Adenocarcinoma: CALGB 30406 Trial

PURPOSE: Erlotinib is clinically effective in patients with non–small-cell lung cancer (NSCLC) who have adenocarcinoma, are never or limited former smokers, or have EGFR mutant tumors. We investigated the efficacy of erlotinib alone or in combination with chemotherapy in patients with these characte...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Jänne, Pasi A., Wang, Xiaofei, Socinski, Mark A., Crawford, Jeffrey, Stinchcombe, Thomas E., Gu, Lin, Capelletti, Marzia, Edelman, Martin J., Villalona-Calero, Miguel A., Kratzke, Robert, Vokes, Everett E., Miller, Vincent A.
Format: Artigo
Sprog:Inglês
Udgivet: American Society of Clinical Oncology 2012
Fag:
Original Reports
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3397694/
https://ncbi.nlm.nih.gov/pubmed/22547605
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2011.40.1315
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker